Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Pediatric Endocrinology and Metabolism

Editor-in-Chief: Kiess, Wieland

Ed. by Bereket, Abdullah / Darendeliler, Feyza / Dattani, Mehul / Gustafsson, Jan / Luo, Fei Hong / Mericq, Veronica / Toppari, Jorma

IMPACT FACTOR 2018: 1.239

CiteScore 2018: 1.22

SCImago Journal Rank (SJR) 2018: 0.507
Source Normalized Impact per Paper (SNIP) 2018: 0.562

See all formats and pricing
More options …
Volume 32, Issue 10


Validation of a risk screening tool for pediatric type 1 diabetes patients: a predictor of increased acute health care utilization

Bethany A. Glick
  • Corresponding author
  • Nationwide Children’s Hospital, Pediatric Endocrinology, 700 Children’s Drive, Columbus, OH 43205, USA, Phone: +614-722-8836, Fax: +614-722-4440
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ K. Ming Chan Hong / Don Buckingham / Melissa Moore-Clingenpeel
  • Nationwide Children’s Hospital, Biostatistics Core and Critical Care Medicine, Columbus, OH, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Ann Salvator
  • Nationwide Children’s Hospital, Biostatistics Core and Critical Care Medicine, Columbus, OH, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Manmohan K. Kamboj
  • Nationwide Children’s Hospital, Ohio State University, Pediatric Endocrinology, Columbus, OH, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-09-06 | DOI: https://doi.org/10.1515/jpem-2019-0156



Both psychosocial and socioeconomic risk factors contribute to poor glycemic control (GC). Previous research has identified that diabetes care behaviors are generally ‘set’ by late childhood, further highlighting the importance of psychosocial screening and intervention in the early course of disease management. The purpose of the current study was to determine whether this brief risk assessment tool is associated with GC and acute health care (HC) utilization, and to evaluate the discriminatory utility of the tool for predicting poor outcomes.


This was a retrospective cohort design in which we compared risk assessment scores with health outcomes at 6, 12, and 18 months after new-onset type 1 diabetes diagnosis for 158 patients between 2015 and 2017. The two primary outcome variables were GC and acute HC utilization.


Our data demonstrate that the greatest utility of the tool is for predicting increased acute HC utilization. It was most useful in differentiating between patients with vs. without any acute HC utilization, with excellent discriminatory ability (area under the receiver operator characteristic curve [AUC] = 0.93), sensitivity (90%), and specificity (97%).


Knowledge of the risk category in addition to identification of individual risk factors within each domain allows for not only clear treatment pathways but also individualized interventions. The risk assessment tool was less effective at differentiating patients with poor GC; however, the tool did have high specificity (83%) for predicting poor GC at 18 months which suggests that the tool may also be useful for predicting patients at risk for poor GC.

Keywords: acute health care utilization; hemoglobin A1c; psychosocial risk; type 1 diabetes


  • 1.

    American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care 2018;41:917–28.PubMedGoogle Scholar

  • 2.

    Maahs DM, Hermann JM, Holman N, Foster NC, Kapellen TM, et al. Rates of diabetic ketoacidosis: international comparison with 49,859 pediatric patients with type 1 diabetes from England, Wales, the U.S., Austria, and Germany. Diabetes Care 2015;38:1876–82.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 3.

    Cameron FJ, Northam EA, Ambler GR, Daneman D. Routine psychological screening in youth with type 1 diabetes and their parents. A notion whose time has come? Diabetes Care 2007;30:2716–24.PubMedCrossrefWeb of ScienceGoogle Scholar

  • 4.

    Cameron FJ, Smidts D, Hesketh K, Wake M, Northam EA. Early detection of emotional and behavioural problems in children with diabetes: the validity of the child health questionnaire as a screening instrument. Diabet Med 2003;20:646–50.CrossrefGoogle Scholar

  • 5.

    La Greca AM. It’s ‘all in the family’: responsibility for diabetes care. J Pediatr Endocrinol Metab 1998;11(Suppl 2): 379–85.Google Scholar

  • 6.

    Hassan K, Loar R, Anderson BJ, Heptulla RA. The role of socioeconomic status, depression, quality of life, and glycemic control in type 1 diabetes mellitus. J Pediatr 2006;149:526–31.CrossrefPubMedGoogle Scholar

  • 7.

    Kazak AE, Schneider S, Didonato S, Pai AL. Family psychosocial risk screening guided by the pediatric psychosocial preventative health model (PPPHM) using the psychosocial assessment tool (PAT). Acta Oncol 2015;54:574–80.CrossrefWeb of SciencePubMedGoogle Scholar

  • 8.

    Schwartz DD, Cline VD, Axelrad ME, Anderson BJ. Feasibility, acceptability, and predictive validity of a psychosocial screening program for children and youth newly diagnosed with type 1 diabetes. Diabetes Care 2011;34:326–31.CrossrefWeb of SciencePubMedGoogle Scholar

  • 9.

    American Diabetes Association. Children and adolescents: standards of medical care in diabetes. Diabetes Care 2019;42(Suppl 1):S148–64.PubMedGoogle Scholar

  • 10.

    Silverstein J, Klingensmith G, Copeland K, Plotnick L, Kaufman F, et al. Care of children and adolescents with type 1 diabetes. Diabetes Care 2005;28:186–212.CrossrefPubMedGoogle Scholar

  • 11.

    Dabadghao P, Vidmar S, Cameron FJ. Deteriorating diabetic control through adolescence – do the origins lie in childhood? Diabet Med 2001;18:889–94.PubMedCrossrefGoogle Scholar

  • 12.

    Schwartz DD, Axelrad ME, Anderson BJ. A psychosocial risk index for poor glycemic control in children and adolescents with type 1 diabetes. Pediatr Diabetes 2014;15:190–7.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 13.

    Grimsby JL, Porneala BC, Vassy JL, Yang Q, Florez JC, et al. Race-ethnic differences in the association of genetic loci with HbA1c levels and mortality in U.S. adults: the third national health and nutrition examination survey (NHANES III). BMC Med Genet 2012;13:30.PubMedCrossrefGoogle Scholar

  • 14.

    Cohen DM, Lumley MA, Naar-King S, Partridge T, Cakan N. Child behavior problems and family functioning as predictors of adherence and glycemic control in economically disadvantaged children with type 1 diabetes: a prospective study. J Pediatr Psychol 2004;29:171–84.CrossrefPubMedGoogle Scholar

  • 15.

    Delamater AM. Psychological care of children and adolescents with diabetes. Pediatr Diabetes 2009;10(Suppl 12):175–84.Web of SciencePubMedCrossrefGoogle Scholar

  • 16.

    Gerstl EM, Rabl W, Rosenbauer J, Gröbe H, Hofer S, et al. Metabolic control as reflected by HbA1c in children, adolescents and young adults with type 1 diabetes mellitus: combined longitudinal analysis including 27,035 patients from 207 centers in Germany and Austria during the last decade. Eur J Pediatr 2008;167:447–53.CrossrefGoogle Scholar

  • 17.

    Grey M, Boland EA, Yu C, Sullivan-Bolyai S, Tamborlane WV. Personal and family factors associated with quality of life in adolescents with diabetes. Diabetes Care 1998;21:909–14.CrossrefPubMedGoogle Scholar

  • 18.

    Northam E, Anderson P, Adler R, Werther G, Warne G. Psychosocial and family functioning in children with insulin-dependent diabetes at diagnosis and one year later. J Pediatr Psychol 1996;21:699–717.PubMedCrossrefGoogle Scholar

  • 19.

    Rewers A, Chase H, Mackenzie T, Walravens P, Roback M, et al. Predictors of acute complications in children with type 1 diabetes. J Am Med Assoc 2002;287:2511–8.CrossrefGoogle Scholar

  • 20.

    Schwartz D, Depp Cline V, Hansen JA, Axelrad M, Anderson BJ. Early risk factors for nonadherence in pediatric type 1 diabetes: a review of the recent literature. Curr Diabetes Rev 2010;6:167–83CrossrefPubMedGoogle Scholar

  • 21.

    Stallwood L. Influence of caregiver stress and coping on glycemic control of young children with diabetes. J Pediatr Health Care 2005;19:293–300.CrossrefPubMedGoogle Scholar

  • 22.

    Orchard T, Becker DJ, Kuller LH, Wagener DK, Laporte R, et al. Age and sex variations in glucose tolerance and insulin responses: parallels with cardiovascular risk. J Chronic Dis 1982;35:123–32.PubMedCrossrefGoogle Scholar

  • 23.

    Petitti DB, Klingensmith GJ, Bell RA, Andrews JS, Dabelea D, et al. Glycemic control in youth with diabetes: the SEARCH for diabetes in youth study. J Pediatr 2009;155:668–72.e3.PubMedCrossrefGoogle Scholar

  • 24.

    Springer D, Dziura J, Tamborlane WV, Steffen AT, Ahern JH, et al. Optimal control of type 1 diabetes mellitus in youth receiving intensive treatment. J Pediatr 2006;149:227–32.CrossrefPubMedGoogle Scholar

  • 25.

    Patton SR, Dolan LM, Henry R, Powers SW. Fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings 2008;15:252–9.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 26.

    Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, et al. A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns 2007;68:10–5.Web of SciencePubMedCrossrefGoogle Scholar

  • 27.

    Abdul-Rasoul M, Habib H, Al-Khouly M. ‘The honeymoon phase’ in children with type 1 diabetes mellitus: frequency, duration, and influential factors. Pediatr Diabetes 2006;7:101–7.PubMedCrossrefGoogle Scholar

  • 28.

    Schölin A, Björklund L, Borg H, Arnqvist H, Björk E, et al. Islet antibodies and remaining β-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide diabetes incidence study in Sweden. J Intern Med 2004;255:384–91.CrossrefPubMedGoogle Scholar

  • 29.

    Alan MJ, Hauser ST, Lavori P, Wolfsdorf JI, Herskowitz RD, et al. Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: I. The influence of patient coping and adjustment. J Pediatr Psychol 1990;15:511–26.CrossrefGoogle Scholar

  • 30.

    Svoren BM, Butler D, Levine B-S, J Anderson B, Laffel LM. Reducing acute adverse outcomes in youths with type 1 diabetes: a randomized, controlled trial. Pediatrics 2003;112:914–22.CrossrefPubMedGoogle Scholar

  • 31.

    Kahana S, Drotar D, Frazier T. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol 2008;33:590–611.Web of SciencePubMedCrossrefGoogle Scholar

  • 32.

    Shilling V, Morris C, Thompson-Coon J, Ukoumunne O, Rogers M, et al. Peer support for parents of children with chronic disabling conditions: a systematic review of quantitative and qualitative studies. Dev Med Child Neurol 2013;55:602–9.PubMedWeb of ScienceCrossrefGoogle Scholar

About the article

Received: 2019-03-30

Accepted: 2019-07-03

Published Online: 2019-09-06

Published in Print: 2019-10-25

Author contributions: The authors declare no relevant conflict of interest. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None declared.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Citation Information: Journal of Pediatric Endocrinology and Metabolism, Volume 32, Issue 10, Pages 1155–1162, ISSN (Online) 2191-0251, ISSN (Print) 0334-018X, DOI: https://doi.org/10.1515/jpem-2019-0156.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in